Healthcare provider profile · identity verified

Daryll Brosanders, M.D.

Family Practice · TUCSON, AZ · NPI 1144258880

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	447	170
Lisinopril	Lisinopril	401	133
Amlodipine Besylate	Amlodipine Besylate	387	117
Gabapentin	Gabapentin	332	91
Losartan Potassium	Losartan Potassium	219	73
Levothyroxine Sodium	Levothyroxine Sodium	216	59
Hydrochlorothiazide	Hydrochlorothiazide	192	63
Metformin Hcl	Metformin Hcl	191	66
Omeprazole	Omeprazole	190	60
Trazodone Hcl	Trazodone Hcl	168	42
Tamsulosin Hcl	Tamsulosin Hcl	138	52
Trulicity	Dulaglutide	131	25
Fluticasone Propionate	Fluticasone Propionate	123	58
Pantoprazole Sodium	Pantoprazole Sodium	120	45
Lovastatin	Lovastatin	116	38
Albuterol Sulfate Hfa	Albuterol Sulfate	115	44
Metoprolol Tartrate	Metoprolol Tartrate	112	33
Pregabalin	Pregabalin	95	16
Sertraline Hcl	Sertraline Hcl	95	33
Metoprolol Succinate	Metoprolol Succinate	92	33
Famotidine	Famotidine	89	30
Hydralazine Hcl	Hydralazine Hcl	82	26
Glipizide	Glipizide	77	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	74	27
Metformin Hcl Er	Metformin Hcl	72	29
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	72	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	69	18
Potassium Chloride	Potassium Chloride	63	19
Chlorthalidone	Chlorthalidone	61	23
Diclofenac Sodium	Diclofenac Sodium	60	30
Eliquis	Apixaban	58	17
Ozempic	Semaglutide	58	13
Prednisone	Prednisone	57	28
Glipizide Er	Glipizide	54	19
Ibuprofen	Ibuprofen	54	21
Jardiance	Empagliflozin	53	23
Single Use Swab	Alcohol Antiseptic Pads	51	29
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	47	21
Donepezil Hcl	Donepezil Hcl	46	13
Ciclopirox	Ciclopirox	45	27
Meloxicam	Meloxicam	45	17
Meclizine Hcl	Meclizine Hcl	43	16
Furosemide	Furosemide	42	18
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	40	39
Alendronate Sodium	Alendronate Sodium	40	17
Shingrix	Varicella-Zoster Ge/As01b/Pf	40	38
Triamcinolone Acetonide	Triamcinolone Acetonide	40	25
Carvedilol	Carvedilol	39	17
Pravastatin Sodium	Pravastatin Sodium	39	14
Montelukast Sodium	Montelukast Sodium	36	11
Escitalopram Oxalate	Escitalopram Oxalate	35	14
Mirtazapine	Mirtazapine	35	suppressed
Duloxetine Hcl	Duloxetine Hcl	34	11
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	33	11
Oxycodone Hcl	Oxycodone Hcl	33	suppressed
Spironolactone	Spironolactone	33	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	32	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	suppressed
Xarelto	Rivaroxaban	32	14
Ondansetron Hcl	Ondansetron Hcl	31	suppressed
Finasteride	Finasteride	30	12
Hydroxyzine Hcl	Hydroxyzine Hcl	30	15
Januvia	Sitagliptin Phosphate	30	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	29	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	29	18
Atrovent Hfa	Ipratropium Bromide	28	14
Atenolol	Atenolol	27	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	27	26
Doxycycline Hyclate	Doxycycline Hyclate	26	21
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Ondansetron Odt	Ondansetron	25	12
Allopurinol	Allopurinol	24	suppressed
Estradiol	Estradiol	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Topiramate	Topiramate	23	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	22	11
Dulera	Mometasone/Formoterol	21	suppressed
Lactulose	Lactulose	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Nifedipine Er	Nifedipine	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	21	suppressed
Sucralfate	Sucralfate	21	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Hydrocortisone	Hydrocortisone	18	13
Naproxen	Naproxen	18	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	17	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Methotrexate	Methotrexate Sodium	17	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	16	suppressed
Valsartan	Valsartan	16	suppressed
Metronidazole	Metronidazole	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	14	suppressed
Clopidogrel	Clopidogrel Bisulfate	14	suppressed
Insulin Lispro	Insulin Lispro	14	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	14	suppressed
Varenicline Tartrate	Varenicline Tartrate	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Cephalexin	Cephalexin	13	12
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	13	suppressed
Humulin N	Insulin Nph Human Isophane	13	suppressed
Proctosol-Hc	Hydrocortisone	13	suppressed
Clonazepam	Clonazepam	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Promethazine Hcl	Promethazine Hcl	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Baclofen	Baclofen	11	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error